Arbutus Biopharma Corporation(NASDAQ:ABUS) 
Arbutus Biopharma Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of a cure for patients suffering from chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously-del...
Website: http://www.arbutusbio.com
Founded: 2007
Full Time Employees: 78
CEO: William Bill Collier
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 3.41
H 3.46
L 3.17
C 3.23
V 1,537,723
10EMA 3.23
20EMA 3.23
60EMA 3.23
120EMA 3.23
250EMA 3.23